Issue Date | Title | Author(s) |
2016 | Assessment of the new 2012 EULAR/ACR clinical classification criteria for polymyalgia rheumatica: A prospective multicenter study | Ozen, G. ; Inanc, N.; Unal, A.U.; Bas, S.; Kimyon, G.; Kisacik, B.; Onat, A.M. |
2015 | Behçet disease with vascular involvement: Effects of different therapeutic regimens on the incidence of new relapses | Alibaz-Oner, F.; Karadeniz, A.; Yilmaz, S.; Balkarli, A.; Kimyon, G.; Yazici, A.; Çinar, M. |
2014 | Evaluation of frequency and the attacks features of patients with colchicine resistance in FMF | Cetin, G.Y.; Balkarli, A.; Öksüz, A.N.; Kimyon, G.; Pehlivan, Y.; Orhan, O. ; Kisacik, B. |
2015 | Incidence of cyclophosphamide-induced urotoxicity and protective effect of mesna in rheumatic diseases | Yilmaz, N.; Emmungil, H.; Gücenmez, Sercan; Ozen, G. ; Yildiz, F.; Balkarli, A.; Kimyon, G. |
2016 | The management of gout in different clinical specialties in Turkey: a patient-based survey | Öztürk, M.A.; Mercan, R.; Gök, K.; Onat, A.M.; Kısacık, B.; Kimyon, G.; Balkarlı, Ayşe |
2016 | Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort | Kalyoncu, U.; Solmaz, D.; Emmungil, H.; Yazici, A.; Kasifoglu, T.; Kimyon, G.; Balkarlı, Ayşe |